Safeguarding Trial Participants: The Role of IRB/IEC

Author name

By: Bethel T. | March 29, 2024

 



“The purpose of an IRB/IEC is to safeguard the rights, safety and well-being of all trial participants.” (1)


 

Clinical trials are pivotal in the progression of medical understanding and the enhancement of patient care. However, ensuring the ethical conduct of these trials is paramount. This is where Institutional Review Boards (IRBs) or Independent Ethics Committees (IECs) come into play. Their primary purpose is to safeguard the rights, safety, and well-being of all trial participants. This blog delves into the pivotal role of Institutional Review Boards (IRBs) or Independent Ethics Committees (IECs) in the clinical trial process and their unwavering dedication to maintaining ethical standards.


Protecting Participants' Rights and Welfare


Ethical Review


IRBs/IECs are responsible for conducting ethical reviews of proposed clinical trials. They thoroughly assess the trial protocols, informed consent forms, and the overall risk-benefit ratio to ensure that the rights and well-being of trial participants are prioritized.


Informed Consent


These committees ensure that participants are provided with clear and comprehensive information about the trial, including its purpose, procedures, potential risks, and benefits. They review the informed consent documents to ensure that participants can make an informed decision about their involvement in the trial.


Upholding Ethical Standards


Regulatory Compliance


IRBs/IECs operate in accordance with local regulations and international ethical guidelines, such as the Declaration of Helsinki and the International Council for Harmonization (ICH) guidelines. They ensure that trials adhere to these standards throughout the trial process.


Ongoing Oversight


These committees provide ongoing oversight of clinical trials, monitoring any changes to the trial protocol, participant recruitment, and safety data. This oversight helps to maintain the integrity of the trial and protect the rights and safety of participants.

Collaboration and Expertise


Multidisciplinary Expertise


IRBs/IECs consist of multidisciplinary teams, including medical professionals, scientists, ethicists, and community representatives. This diverse expertise ensures a comprehensive evaluation of the scientific, ethical, and social aspects of clinical trials.


Collaboration with Researchers


While their primary role is to protect participants, IRBs/IECs also collaborate with researchers to address ethical concerns and improve the quality of the trial. This partnership ensures that ethical considerations are integrated into the trial design and conduct.

Conclusion


The diligent efforts of Institutional Review Boards (IRBs) or Independent Ethics Committees (IECs) are paramount in safeguarding the integrity and ethical conduct of clinical trials. By steadfastly upholding ethical standards and placing utmost emphasis on the rights and well-being of participants, these committees assume a pivotal role in advancing medical research while concurrently ensuring the highest standards of participant protection.


In summary, the dedication of Institutional Review Boards (IRBs) or Independent Ethics Committees (IECs) to safeguarding the rights, safety, and well-being of trial participants is fundamental to the ethical conduct of clinical trials. Their meticulous oversight and ethical review procedures bolster the credibility and integrity of the clinical trial process, ultimately serving the interests of both participants and the progress of medical science.

 



REFERENCE



    1.       International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, ICH Harmonised Guideline Good Clinical Practice (GCP) E6(R3), Section 1.1.1, https://database.ich.org/sites/default/files/ICH_E6%28R3%29_DraftGuideline_2023_0519.pdf

March 21, 2024
By: Bethel T. March 22, 2024 “Trial processes should be operationally feasible and avoid unnecessary complexity, procedures and data collection. Trial processes should support the key trial objectives.” ICH-GCP E6R3 Section 9.3 (1) Clinical trials are crucial for testing the safety and efficacy of new treatments and medical interventions. However, the complexity of trial processes can sometimes hinder their operational feasibility. To ensure streamlined and effective trial processes, it's important to avoid unnecessary complexity and procedures while ensuring that they support the key trial objectives. Understanding Operational Feasibility Operational feasibility refers to the practicality of conducting a clinical trial within the available resources and constraints. This encompasses various aspects, including financial resources, human resources, time, and technology. Simplifying trial processes can significantly enhance operational feasibility by reducing the burden on these resources. Streamlining Procedures Complicated and burdensome procedures not only raise the cost and duration of conducting a trial but also discourage potential participants and result in data inaccuracies. Therefore, it's essential to streamline procedures by: Simplifying Data Collection: Focusing on collecting essential data that directly aligns with the trial objectives can prevent the unnecessary burden of collecting excessive data. Minimizing Administrative Burden: Reducing administrative tasks for both trial organizers and participants can streamline the process and make it more efficient. Optimizing Participant Recruitment: Implementing straightforward and clear participant recruitment processes can enhance the efficiency of trial enrollment. Supporting Key Trial Objectives While simplifying trial processes, it's crucial to ensure that the streamlined procedures continue to support the key trial objectives, such as ensuring participant safety, collecting reliable data, and achieving meaningful outcomes. This can be achieved by: Prioritizing Safety Protocols: Simplification should not come at the cost of compromising participant safety. The trial processes must continue to uphold rigorous safety protocols. Emphasizing Data Quality: Despite simplification, measures should be in place to maintain the quality and integrity of the collected data, ensuring that it is robust and reliable. Focusing on Outcome Relevance: The streamlined procedures should closely match the intended goals of the trial, guaranteeing that the gathered data is relevant to the research objectives. Embracing Technology Advancements in technology offer opportunities to simplify trial processes significantly. Incorporating Electronic Data Capture Systems, Remote Monitoring Technologies and digital communication platforms (Messaging apps, Video Conferencing Platforms, Email Platforms, Social Media Platforms, etc.) can streamline data collection, enhance participant engagement, and reduce the administrative burden by automating tasks, enabling remote monitoring, and facilitating communication between researchers and participants. Examples of these devices include: Incorporating electronic data capture systems: Viedoc: Viedoc is an EDC platform designed to streamline data collection and enhance the efficiency of clinical research. It offers features such as seamless collaboration, real-time data access, and analysis capabilities. Medidata Rave: Medidata Rave is an advanced and secure EDC system known for its flexibility, adaptability to various study sizes, and real-time data validation and surveillance features. It also provides robust reporting and analysis tools for informed decision-making. Klindat: Klindat, developed by Zlynger, is a powerful and secure EDC system designed to simplify the collection, cleaning, and processing of data in clinical trials. It offers a user-friendly interface, accessibility through the Internet, and robust data management features. Remote Monitoring Technologies: Blood Pressure Cuff: determines a patient’s heart rate and blood circulation by assessing variations in artery movement. The Bluetooth-enabled blood pressure cuff resembles the conventional device used in medical settings, with the crucial distinction of transmitting data instantly to the clinician for evaluation. Blood Glucose Meter: analyze a patient’s blood sugar levels using a tiny blood sample applied to a test strip linked to the device. The patient applies a small blood drop to the test strip, which is scanned by the meter to generate the blood glucose measurement. Subsequently, the measurement is transmitted instantaneously to the healthcare provider for assessment. Pulse Oximeter: is a non-invasive clip attached to the patient’s finger (or occasionally the earlobe) to measure light wavelengths that determine the blood oxygen level, indicating the oxygen saturation in the patient’s red blood cells. Additionally, the pulse oximeter records the patient’s pulse. Enhancing operational feasibility and maximizing the efficiency of valuable research endeavors necessitate the simplification of trial processes. Through the strategic streamlining of procedures, alignment with key trial objectives, and wholehearted integration of technology, clinical trials can attain heightened accessibility, cost-effectiveness, and, consequently, greater impact in advancing medical knowledge and elevating patient care standards. It's essential to underscore that the simplification of trial processes should not be misconstrued as sacrificing quality or rigor. Rather, it entails strategically optimizing the allocation of resources and refining procedures to ensure the attainment of optimal outcomes for all stakeholders engaged in the clinical trial process. REFERENCE International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, ICH Harmonised Guideline Good Clinical Practice (GCP) E6(R3), Section 9.3, https://database.ich.org/sites/default/files/ICH_E6%28R3%29_DraftGuideline_2023_0519.pdf
Share by: